Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2006
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)C Kollmannsberger, M Schittenhelm, F Honecker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2007
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study GroupC Bokemeyer, K Oechsle, F Honecker, et al.
British Journal of Cancer|October 29, 2002
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancerC Bokemeyer, K Oechsle, J T Hartmann, et al.
British Journal of Cancer|March 1, 2002
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PETC Bokemeyer, C Kollmannsberger, K Oechsle, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Der Urologe. Ausg. A|October 31, 2018
[Positron emission tomography in germ cell tumors in men : Possibilities and limitations]P Schriefer, M Hartmann, K Oechsle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2001
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminomaM De Santis, C Bokemeyer, A Becherer, et al.
European Journal of Cancer Care|April 28, 2018
The daily dynamics of loss orientation and life engagement in advanced cancer: A pilot study to characterise patterns of adaptation at the end of lifeS Vehling, D Gerstorf, F Schulz-Kindermann, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 9, 2004
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker]A C Pfannenberg, K Oechsle, C Kollmannsberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry StudyC Oing, K Oechsle, A Necchi, et al.
Pageof 4